MCP 60 Seconds With Dr Adil Bharucha on Enrollment in Decentralized Studies
View Full-Length Video at: https://youtu.be/4z_ple_-FPARelated Article Available at: https://mayocl.in/3CIyHpX
Related Articles
Coordinating Multidisciplinary Care — Improving Outcomes after Fragility Fractures | NEJM
Making integrated fracture liaison services a routine part of postfracture care could help reduce disparities in care — and may offer a useful model for…
RSV vaccines: Questions patients may have and how to answer
Respiratory syncytial virus (RSV) season often starts in the fall and peaks in winter. RSV vaccines are available to help reduce risk for severe illness.
Are Your Gums Healthy? How To Tell and Boost Gum Health
You may forget about your gums sometimes. But healthy gums are just as important as healthy teeth. Here’s how to know if your gums are…
Ruptured Grade 5 Brain Aneurysm: Case Study of a Patient Who Beat the Odds
Case of a 38-year-old who beat the odds against the 90% fatality rate for grade 5 brain aneurysm and has returned to many daily activities.…
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
The list of 15 more of the priciest medications selected for the negotiation program is supposed to be released by Feb. 1.
State-by-state breakdown of new hospitals in 2024
A state-by-state breakdown of over 80 acute care hospital projects announced, initiated, or opened in 2024.
JPM25: Vertex CEO says pain is its next multi-billion franchise
Vertex’s leaders projected confidence in the firm’s non-opioid pain franchise at the JP Morgan Healthcare Conference on Monday, although the first cut of data for…
AI datacenter frenzy pushes 2024 M&A activity to new high
Fewer giant deals, but many more smaller ones, in bit barn feeding frenzy
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Report Positive Topline Data from 8 mg Dose of Phase 2 Obesity Trial of GLP-1/GIP Receptor Dual Agonist HRS9531 – Kailera
– Statistically significant mean weight loss of 22.8% (21.1% placebo adjusted) at 36 weeks; 59% of HRS9531-treated participants lost 20% or more of their baseline…
ReThink Meat
In this eight-part, eye-opening docuseries ReThink Meat, we explore the environmental impact of sustainable, regenerative livestock farming. With insights fr…
